A cost-effectiveness analysis of epoetin usage for patients with AIDS.

Abstract

Epoetin (recombinant human erythropoietin) therapy for patients with AIDS may reduce the need for blood transfusion; however, it is expensive. We conducted a cost-effectiveness analysis of the use of epoetin for AIDS patients from a healthcare system perspective. We constructed a decision analysis model using probability, outcome and cost data from the… (More)

Topics

Cite this paper

@article{Cantor1993ACA, title={A cost-effectiveness analysis of epoetin usage for patients with AIDS.}, author={Scott B. Cantor and Richard W Carson and Stephen Spann}, journal={PharmacoEconomics}, year={1993}, volume={3 3}, pages={244-9} }